The North America wound care market is expected to grow from US$ 7,920.27 million in 2022 to US$ 11,178.22 million by 2028. It is estimated to register a CAGR of 5.9% from 2022 to 2028.
Rising Chronic Disease Rates Drive Growth in North America’s Wound Care Market
Chronic diseases like diabetes, cancer, and autoimmune disorders significantly impair the body’s natural healing process, increasing the demand for advanced wound care solutions. Diabetes, in particular, disrupts immune function, leading to complications in wound healing. According to the NCBI, approximately 500 million people worldwide suffer from diabetes mellitus (DM), with cases expected to rise. In the U.S. alone, diabetes-related medical costs and lost productivity exceed $300 billion annually.
Research from the National Center for Biotechnology Information (NCBI) indicates that one in three people—and one in five diabetic patients—will develop chronic non-healing wounds, such as diabetic foot ulcers (DFUs), in their lifetime. The hyperglycemic conditions in diabetic patients promote biofilm formation, making wounds harder to treat. This prolonged healing process necessitates long-term wound care, boosting demand for specialized dressings.
Additionally, the growing prevalence of cancer has led to an increase in surgical interventions, where advanced wound dressings—such as hydrogels, alginates, and foams—are essential for managing post-operative wounds and preventing infections. As chronic diseases continue to rise, so does the need for effective wound care solutions, driving market expansion across North America.
North America Wound Care Market Overview
The North America wound care market is segmented into the U.S., Canada, and Mexico, with the U.S. leading in market share as of 2022. Chronic ulcers and diabetes are major contributors to wound-related healthcare burdens in the region. Studies from the National Library of Medicine estimate that chronic ulcer treatments cost the U.S. healthcare system up to 28 billion annually for primary diagnoses and 31.7 billion for secondary cases.
The American Diabetes Association (ADA) reports that 9–12 million Americans suffer from chronic ulcers, with amputation-related mortality rates reaching 70% within five years. Furthermore, research indicates that 3% of the U.S. population over 65 has open wounds. With the elderly population projected to surpass 77 million by 2060, the demand for wound care solutions is expected to grow significantly.
Strategic Insights for the North America Wound Care Market
To thrive in this competitive market, stakeholders must leverage data-driven insights to identify emerging trends, assess key competitors, and adapt to regional variations. Strategic recommendations include:
- Targeting Underserved Segments: Identifying unmet needs in chronic wound management, particularly for diabetic and elderly patients.
- Innovation in Advanced Dressings: Expanding the use of hydrogels, antimicrobial dressings, and bioactive wound care products.
- Regulatory and Economic Adaptation: Tailoring strategies to comply with regional healthcare policies and economic conditions.
A forward-looking approach is critical for anticipating market shifts, ensuring long-term growth, and maintaining a competitive edge.
Regional Market Dynamics
The North America wound care market growth is influenced by localized factors, including:
- U.S. Dominance: Driven by high chronic disease prevalence, an aging population, and significant healthcare expenditure.
- Canada & Mexico: Emerging opportunities due to increasing diabetes rates and improving healthcare infrastructure.
- Consumer Preferences: Demand varies by region, with some markets prioritizing advanced wound care technologies over traditional solutions.
By understanding these regional nuances, businesses can optimize resource allocation, refine marketing strategies, and strengthen their market position. With chronic wounds posing an ongoing challenge, the North America wound care market is poised for sustained expansion across North America.
North America wound care market Segments Covered
North America wound care market By Product
- Advanced Wound Dressing
- Surgical Wound Care
- Traditional Wound Care
- Wound Therapy Devices
North America wound care market By Wound Type
- Chronic Wounds
- Acute Wounds
North America wound care market By End User
- Hospitals
- Specialty Clinics
- Home Healthcare
North America wound care market Regions and Countries Covered
North America
- US
- Canada
- Mexico
North America wound care market leaders and key company profiles
- 3M Co
- Baxter International Inc
- Coloplast AS
- ConvaTec Group Plc
- Ethicon USA LLC
- Integra LifeSciences Holdings Corp
- Medtronic Plc
- MiMedx
- PAUL HARTMANN AG
- Smith & Nephew Plc
Other Reports:
North America Gummy Supplements Market: https://penzu.com/p/8503c42ca09ae4f7
North America Radiation-Hardened Electronics Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/26
North America mHealth Market: https://sites.google.com/view/n-mhealth-market/home
North America Synthetic Biology Market: https://business-news-insights.blogspot.com/2025/05/north-america-synthetic-biology-market.html
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
